Salomon & Ludwin’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.9K Buy
2,129
+768
+56% +$13.4K ﹤0.01% 525
2025
Q4
$17.3K Sell
1,361
-69
-5% -$886 ﹤0.01% 1016
2025
Q3
$23.1K Buy
1,430
+1,180
+472% +$17.1K ﹤0.01% 730
2025
Q2
$3.18K Hold
250
﹤0.01% 609
2025
Q1
$3.38K Hold
250
﹤0.01% 546
2024
Q4
$4.22K Hold
250
﹤0.01% 529
2024
Q3
$5.08K Hold
250
﹤0.01% 525
2024
Q2
$5.64K Hold
250
﹤0.01% 515
2024
Q1
$6.57K Hold
250
﹤0.01% 601
2023
Q4
$7.01K Hold
250
﹤0.01% 538
2023
Q3
$7.01K Buy
+250
New +$8.58K ﹤0.01% 536
2020
Q2
Sell
-15
Closed 94
2020
Q1
$0 Hold
15
﹤0.01% 228
2019
Q4
$0 Hold
15
﹤0.01% 234
2019
Q3
$0 Hold
15
﹤0.01% 210
2019
Q2
$0 Hold
15
﹤0.01% 216
2019
Q1
$1K Buy
+15
New +$546 ﹤0.01% 232

Other funds holding CC

Salomon & Ludwin's CC Position: Q1 2026 in Review

Salomon & Ludwin increased its Chemours (CC) stake by 56% in Q1 2026, buying an estimated $13.4K and bringing the position to 2,129 shares worth $45.9K. The position accounts for ﹤0.01% of the portfolio, ranked #525.

Salomon & Ludwin first reported a position in CC in Q1 2019 and has held it in 16 quarters since. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Salomon & Ludwin held 2,129 shares of Chemours worth $45.9K as of Q1 2026.
  • Salomon & Ludwin bought 768 Chemours shares in Q1 2026, an estimated $13.4K.
  • Chemours made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #525 holding.
  • Salomon & Ludwin first reported a position in Chemours in Q1 2019 and has held it in 16 quarters since.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.